NovaBay Pharmaceuticals

$0.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-4.55%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell NBY and other stocks, options, ETFs, and crypto commission-free!

About NBY

NovaBay Pharmaceuticals, Inc., also called NovaBay Pharmaceuticals, is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. Read More The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

Employees
70
Headquarters
Emeryville, California
Founded
2000
Market Cap
16.63M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
369.92K
High Today
$0.67
Low Today
$0.59
Open Price
$0.67
Volume
330.39K
52 Week High
$4.04
52 Week Low
$0.229

Collections

NBY News

BenzingaJul 29

New York Community Bancorp, Inc. - What Caused The Opening Gap In NovaBay?

1,193

NBY Earnings

-$0.28
-$0.18
-$0.08
$0.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 14, Pre-Market

More NBY News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.